Physicochemical and technical fundamentals

  • P. Galofré-Mora
Chapter
Part of the Developments in Cardiovascular Medicine book series (DICM, volume 146)

Abstract

In any diagnostic endeavour the greatest amount of morphological and functional information is sought in the least aggressive way possible. For nuclear cardiology, this goal is pursued with the use of radioactive substances which, when properly introduced to the organism, can be detected by nuclear medicine devices. By properly selecting the suitable radioactive substance, its form, its introduction into the organism and the type of detecting device, a wide range of diagnostic studies is available.

Keywords

Positron Emission Tomography Nuclear Cardiology Single Photon Emission Tomography Electronic Unit Scintillation Camera 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Zaret BL, Berger HJ. Techniques of nuclear cardiology. In: Hurst JW, Logue RB, Rackley CE, et al. eds. The heart. New York, McGraw- Hill, 1985: 1809–1858.Google Scholar
  2. 2.
    Wexler JP. Heart update (Guest Editorial). Semin Nucl Med 1987; 17: 88.CrossRefGoogle Scholar
  3. 3.
    Ott RJ. Nuclear medicine in the 1990s: a quantitative physiological approach. Br J Radiol 1989; 62: 421–432.PubMedCrossRefGoogle Scholar
  4. 4.
    Tubis M. Radiopharmaceutics. In: Tubis M, Wolf W, eds. Radiopharmacy. New York, John Wiley, 1976: 405–685.Google Scholar
  5. 5.
    Setoain-Quinquer J, Piera-Peña C, Pavía Segura J. Bases de la medicina nuclear. Radio-fármacos e instrumentaCión. In: Domènech-Torné FM, Setoain-Quinquer J, eds. Imágenes en Medicina Nuclear. Madrid, Idepsa, 1990; 1–15.Google Scholar
  6. 6.
    Sorenson JA, Phelps ME. Basic atomic and nuclear physics. In: Sorenson JA, Phelps ME, eds. Physics in nuclear medicine. New York, Grune & Stratton, 1980; 1–16.Google Scholar
  7. 7.
    Patton JA, Rollo FD. Basic physics of radionuclide imaging. In: Freeman LM, ed. Freeman and Johnson’s clinical radionuclide imaging. Orlando, Grune & Stratton, 1984; 13–54.Google Scholar
  8. 8.
    Sorenson JA, Phelps ME. Decay of radioactivity. In. Sorenson JA, Phelps ME, eds. Physics in nuclear medicine. New York, Grune & Stratton, 1980; 32–48.Google Scholar
  9. 9.
    Pena F, Domènech FM. Isótopos, radiaciones y detectores. In: Domènech FM, Setoain J, Galofré P, eds. Medicina nuclear: aplicaciones diagnösticas de los isótopos radiactivos. Barcelona, Científico-Médica, 1980; 1–11.Google Scholar
  10. 10.
    Sorenson JA, Phelps ME. Modes of radioactive decay. In: Sorenson JA, Phelps ME, eds. Physics in nuclear medicine. New York, Grune & Stratton, 1980; 17–31.Google Scholar
  11. 11.
    Iskandrian AS. Instrumentation and imaging. In: Iskandrian AS ed. Nuclear cardiac imaging: principles and applications. Philadelphia, Davis 1987; 11–42.Google Scholar
  12. 12.
    Sorenson JA, Phelps ME. Production of radionuclides. In: Sorenson JA, Phelps ME, eds. Physics in nuclear medicine. New York, Grune & Stratton, 1980; 119–135.Google Scholar
  13. 13.
    Strauss HW, Elmaleh DR, Boucher CA, McKusick KA. Radiopharmaceuticals for cardiovascular studies. In: Gottschlak A, Hoffer PB, Potchen EJ, eds. Diagnostic nuclear medicine. Baltimore, Williams & Wilkins, 1988; 248–258.Google Scholar
  14. 14.
    Jacobson AF, Parker JA, Royal HD, Silverman KJ, Gervino EV, Kolodny GM. Supine versus upright anterior images: comparison in Tl-201 myocardial scintigraphy. Radiology 1987; 163: 691–695.PubMedGoogle Scholar
  15. 15.
    Sorenson JA, Phelps ME. Internal radiation dosimetry. In: Sorenson JA, Phelps ME, eds. Physics in nuclear medicine. New York, Grune & Stratton, 1980; 170–190.Google Scholar
  16. 16.
    Iskandrian AS. Radiopharmaceuticals and dosimetry. In: Iskandrian AS ed. Nuclear-cardiac imaging: principles and applications. Philadelphia, Davis Co. 1987; 43–53.Google Scholar
  17. 17.
    McAfee JG, Subramanian G. Radioactive agents for imaging. In: Freeman LM, ed. Freeman and Johnson’s clinical radionuclide imaging. Orlando, Grune & Stratton, 1984; 55–179.Google Scholar
  18. 18.
    Schelbert HR. Current status and prospects of new radionuclides and radiopharmaceuticals for cardiovascular nuclear medicine. Semin Nucl Med 1987; 17: 145–181.PubMedCrossRefGoogle Scholar
  19. 19.
    Welch MJ, Kilbourn MR. Positron emitters for imaging. In: Freeman LM, ed. Freeman and Johnson’s clinical radionuclide imaging. Orlando, Grune & Stratton, 1984; 181–202.Google Scholar
  20. 20.
    Mena IG. Short-lived generator-produced radiopharmaceuticals: current status and future applications. In: Lyons KP ed. Cardiovascular nuclear medicine. Norwalk, Appleton & Lange, 1988; 230–237.Google Scholar
  21. 21.
    Bayly RJ, Evans EA, Glover JS, Rabinowitz JL. Synthesis of labeled compounds. In: Tubis M, Wolf W, eds. Radiopharmacy. New York, John Wiley, 1976; 303–378.Google Scholar
  22. 22.
    Cohen Y. Purity and stability of labeled compounds. In: Tubis M, Wolf W, eds. Radio-pharmacy. New York, John Wiley, 1976; 379–401.Google Scholar
  23. 23.
    Tubis M. Quality control of radiopharmaceuticals. In: Tubis M, Wolf W, eds. Radiopharmacy. New York, John Wiley, 1976; 555–577.Google Scholar
  24. 24.
    McAfee JG. Update on radiopharmaceuticals for medical imaging. Radiology 1989; 171: 593–601.PubMedGoogle Scholar
  25. 25.
    Berger HJ, Zaret BL. Radionuclide assessment of cardiovascular performance. In: Freeman LM, ed. Freeman and Johnson’s clinical radionuclide imaging. Orlando, Grune & Stratton, 1984; 364–478.Google Scholar
  26. 26.
    Berman DS, Garcia EV, Maddahi J, Rozanski A. Thallium-201 myocardial perfusion scintigraphy. In: Freeman LM, ed. Freeman and Johnson’s clinical radionuclide imaging. Orlando, Grune & Stratton, 1984; 479–536.Google Scholar
  27. 27.
    Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with the technetium 99m agents. Semin Nucl Med 1991; 21: 173–181.PubMedCrossRefGoogle Scholar
  28. 28.
    Gerundini P, Maffioli L. Cationic complexes of technetium for myocardial imaging. J Nucl Med 1989; 30: 1415–1419.PubMedGoogle Scholar
  29. 29.
    Wackers FJ, Berman DS, Maddahi J, et al. Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety and preliminary comparison to thallium- 201 for myocardial perfusion imaging. J Nucl Med 1989; 30: 301–311.PubMedGoogle Scholar
  30. 30.
    Stewart RE, Schwaiger M, Hutchins GD, et al. Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow. J Nucl Med 1990; 31: 1183–1190.PubMedGoogle Scholar
  31. 31.
    Sporn V, Pérez Balino N, Holman L, et al. Simultaneous measurement function and myocardial perfusion. Clin Nucl Med 1988; 13: 77–81.PubMedCrossRefGoogle Scholar
  32. 32.
    Wilson RA, Shea M, De Landesheere C, et al. Rubidium-82 myocardial uptake and extraction after transient ischemia: PET characteristics. JCAT 1987; 11: 60–66.Google Scholar
  33. 33.
    Cerqueira MD, Jacobson AF. Assessment of myocardial viability with SPECT and PET imaging. AJR 1989; 153: 477–483.PubMedGoogle Scholar
  34. 34.
    Schelbert HR. Radionuclide assessment of myocardial metabolism. In: Freeman LM, ed. Freeman and Johnson’s clinical radionuclide imaging. Orlando, Grune & Stratton, 1984; 563–588.Google Scholar
  35. 35.
    Sorribes M, Fraile M, Castell J, Cortadellas J, Domènech-Torné FM. Monoclonal myosin antibody RllDlOFab in acute myocardial infarction diagnosis. Eur J Nucl Med 1989; 15: 478 (abstract).Google Scholar
  36. 36.
    Galofré P, Garcia MC. Teoría de trazadores. In: Domènech FM, Setoain J, Galofré P eds. Medicina nuclear: aplicaciones diagnósticas de los isótopos radiactivos. Barcelona, Cientifico- Médica, 1980; 37–52.Google Scholar
  37. 37.
    Sorenson JA, Phelps ME. Radiation detectors. In: Sorenson JA, Phelps ME, eds. Physics in nuclear medicine. New York, Grune & Stratton, 1980; 48–72.Google Scholar
  38. 38.
    Rollo FD, Patton JA. Instrumentation and information portrayal. In: Freeman LM, ed. Freeman and Johnson’s clinical radionuclide imaging. Orlando, Grune & Stratton, 1984; 203–259.Google Scholar
  39. 39.
    Galofré P, Domènech FM. Instrumentación. In: Domènech FM, Setoain J, Galofré P eds. Medicina nuclear: aplicaciones diagnósticas de los isótopos radiactivos. Barcelona, Científico- Médica, 1980; 13–28.Google Scholar
  40. 40.
    Wagner HN, Wake R, Nickoloff E, et al. The nuclear stethoscope: a simple device for generation of left ventricular curves. Am J Cardiol 1976; 38: 747–750.PubMedCrossRefGoogle Scholar
  41. 41.
    Anger HO. A new instrument for mapping gamma-ray emitters. Biology and medicine quarterly report UCRL-3653. Washington, 1957.Google Scholar
  42. 42.
    Sorenson JA, Phelps ME. The Anger camera: basic principles. In: Sorenson JA, Phelps ME, eds. Physics in nuclear medicine. New York, Grune & Stratton, 1980; 263–282.Google Scholar
  43. 43.
    Sorenson JA, Phelps ME. The Anger camera: performance characteristics. In: Sorenson JA, Phelps ME, eds. Physics in nuclear medicine. New York, Grune & Stratton, 1980; 48–72.Google Scholar
  44. 44.
    Murphy PH. Acceptance testing and quality control of gamma cameras, including SPECT. J Nucl Med 1987; 28: 1221–1227.PubMedGoogle Scholar
  45. 45.
    NEMA standards publication NU 1–1980. Performance measurements of scintillation cameras. NEMA sales office, 2101 L street, N.W., Washington, D.C. 20037.Google Scholar
  46. 46.
    NEMA standards publication NU 1–1986. Performance measurements of scintillation cameras. NEMA sales office, 2101 L street, N.W., Washington, D.C. 20037.Google Scholar
  47. 47.
    Heller SL, Goodwin PN. SPECT instrumentation: performance, lesion detection and recent innovations. Semin Nucl Med 1987; 17: 184–199.PubMedCrossRefGoogle Scholar
  48. 48.
    Simmons GH. On-line corrections for factors that affect uniformity and linearity. In: Simmons GH ed. The scintillation camera. New York, The society of nuclear medicine, 1988; 46–59.Google Scholar
  49. 49.
    English RJ, Brown SE. Introduction. In: English RJ, Brown SE eds. SPECT, single-photon emission computed tomography: a primer. New York, The Society of Nuclear Medicine, 1986; 1–7.Google Scholar
  50. 50.
    Phelps ME. Emission computed tomography. Semin Nucl Med 1977; 7: 337–365.PubMedCrossRefGoogle Scholar
  51. 51.
    Goodwin PN. Recent developments in instrumentation for emission computed tomography. Semin Nucl Med 1980; 10: 322–334.PubMedCrossRefGoogle Scholar
  52. 52.
    Freeman LM, Blaufox MD. Letter from the editors. Semin Nucl Med 1987; 17: 183.CrossRefGoogle Scholar
  53. 53.
    Ashburn WL, Pettigrew R. Single photon emission computed tomography with a rotating single crystal scintillation camera: cardiac imaging. In: Lyons KP ed. Cardiovascular nuclear medicine. Norwalk, Appleton & Lange, 1988; 181–210.Google Scholar
  54. 54.
    Cerqueira MD, Harp GD, Ritchie JL. Evaluation of myocardial perfusion and function by single photon emission computed tomography. Semin Nucl Med 1987; 17: 200–213.PubMedCrossRefGoogle Scholar
  55. 55.
    Gottschalk SC, Salem D, Lim CB, Wake RH. SPECT resolution and uniformity improvements by noncircular orbit. J Nucl Med 1983; 24: 822–828.PubMedGoogle Scholar
  56. 56.
    Bieszk JA, Hawman EG. Evaluation of SPECT angular sampling effects: continous versus step-and-shoot acquisition. J Nucl Med 1987; 28: 1308–1314.PubMedGoogle Scholar
  57. 57.
    English RJ, Brown SE. Acquisition parameters. In: English RJ, Brown SE eds. SPECT, single-photon emission computed tomography: a primer. New York, The society of nuclear medicine, 1986; 47–68.Google Scholar
  58. 58.
    Eisner RL. Principles of instrumentation in SPECT. J Nucl Med Techn 1985; 13: 23–31.Google Scholar
  59. 59.
    Folks R,Banks L, Plankey M et al. Cardiovascular SPECT. J Nucl Med Techn 1985; 13: 150–159.Google Scholar
  60. 60.
    Maublant JC, Peycelon P, Kwiatkowski F, Lusson JR, Standke RH, Veyre A. Comparison between 180° and 360° data collection in technetium-99m MIBI SPECT of the myocardium. J Nucl Med 1989; 30: 295–300.PubMedGoogle Scholar
  61. 61.
    Fischman AJ, Moore RH, Gill JB, Strauss HW. Gated blood pool tomography: a technology whose time has come. Semin Nucl Med 1989; 19: 13–21.PubMedCrossRefGoogle Scholar
  62. 62.
    Ohtake T, Nishikawa J, Machida K, et al. Evaluation of regurgitation fraction of the left ventricle by gated cardiac blood-pool scanning using SPECT. J Nucl Med 1987; 28: 19–24.PubMedGoogle Scholar
  63. 63.
    English RJ, Brown SE. Image reconstruction. In: English RJ, Brown SE eds. SPECT, single-photon emission computed tomography: a primer. New York, The society of nuclear medicine, 1986; 9–24.Google Scholar
  64. 64.
    English RJ, Brown SE. Processing tecniques. In: English RJ, Brown SE eds. SPECT, single-photon emission computed tomography: a primer. New York, The Society of Nuclear Medicine, 1986; 69–91.Google Scholar
  65. 65.
    Gilland DR,Tsui BMW, McCartney WH, Perry JR, Berg J. Determination of the optimum filter function for SPECT imaging. J Nucl Med 1988; 29: 643–650.PubMedGoogle Scholar
  66. 66.
    Eisner R, Churchwell A, Noever T et al. Quantitative analysis of the tomographic thallium-201 myocardial bullseye display: critical role of correcting for patient motion. J Nucl Med 1988; 29: 91–97.PubMedGoogle Scholar
  67. 67.
    Parker JA. Quantitative SPECT: basic theoretical considerations. Semin Nucl Med 1989; 19: 3–12.PubMedCrossRefGoogle Scholar
  68. 68.
    Kasabali B, Woodard ML, Bekerman C, Pinsky S, Blend MJ. Enhanced sensitivity and specificity of thallium-201 imaging for the detection of regional ischemic coronary disease by combining SPECT with ‘bull’s eye’ analysis. Clin Nucl Med 1989; 14: 484–491.PubMedCrossRefGoogle Scholar
  69. 69.
    English RJ, Brown SE. Quality control requirements. In: English RJ, Brown SE eds. SPECT, single-photon emission computed tomography: a primer. New York, The Society of Nuclear Medicine, 1986; 25–46.Google Scholar
  70. 70.
    Kojima A, Matsumoto M, Takahashi M, Hirota Y, Yoshida H. Effect of spatial resolution on SPECT quantification values. J Nucl Med 1989; 30: 508–514.PubMedGoogle Scholar
  71. 71.
    Cerqueira MD,Matsuoka D, Ritchie JL, Harp GD. The influence of collimators on SPECT center of rotation measurements: artefact generation and acceptance testing. J Nucl Med 1988; 29: 1393–1397.PubMedGoogle Scholar
  72. 72.
    Spinks TJ, Guzzardi R, Bellina CR. Performance characteristics of a whole-body positron tomograph. J Nucl Med 1988; 29: 1833–1841.PubMedGoogle Scholar
  73. 73.
    Ter-Pogossian MM. Special characteristics and potential for dynamic function studies with PET. Semin Nucl Med 1981; 11: 13–31.PubMedCrossRefGoogle Scholar
  74. 74.
    Wong WH. Camera performance design evaluation for BGO and BaF2 scintillators (non-time-of-flight). J Nucl Med 1988; 29: 338–347.PubMedGoogle Scholar
  75. 75.
    Schelbert HR, Henze E, Phelps ME. Emission tomography of the heart. Semin Nucl Med 1980; 10: 355–373.PubMedCrossRefGoogle Scholar
  76. 76.
    Brunken RC, Kottou S, Nienaber CA et al. PET detection of viable tissue in myocardial segments with persistent defects at Tl-201 SPECT. Radiology 1989; 172: 65–73.PubMedGoogle Scholar
  77. 77.
    Schwaiger M, Hutchins GD. Evaluation of coronary artery disease with positron emission tomography. Semin Nucl Med 1992; 22: 210–223.PubMedCrossRefGoogle Scholar
  78. 78.
    Goodwin PN. Radiation safety for patients and personnel. In: Freeman LM, ed. Freeman and Johnson’s clinical radionuclide imaging. Orlando, Grune & Stratton, 1984; 315–328.Google Scholar
  79. 79.
    Galofré-Mora P, Doménech-Torné FM. Medicina nuclear. Eficacia diagnóstica, radio-protección y comparación con otras técnicas. In: Doménech-Torné FM, Setoain Quinquer J, eds. Imgenes en Medicina Nuclear. Madrid, Idepsa, 1990; 16–27.Google Scholar
  80. 80.
    Candell-Riera J, Ramos-Mârquez M. Informe del grupo de trabajo de cardiologia nuclear. Rev Esp Cardiol 1987; 40: 389–396.Google Scholar
  81. 81.
    Clausen M, Civelek AC,Bice AN et al. Short-axis circumferencial profiles of the heart in healthy subjects: comparison of Tl-201 SPECT and two-dimensional echocardiography. Radiology 1988; 168: 723–726.PubMedGoogle Scholar
  82. 82.
    Adam WE. A general comparison of functional imaging nuclear medicine with other modalities. Semin Nucl Med 1987; 17: 3–17.PubMedCrossRefGoogle Scholar
  83. 83.
    Strauss HW, Fischman AJ. Cardiovascular nuclear medicine: the next step. J Nucl Med 1989; 30: 1123–1128.PubMedGoogle Scholar
  84. 84.
    Desco M, García Dorado D. Ultimos avances y perspectivas en las técnicas de diagnóstico cardiológico incruento. In: Asín Cardiel E., ed. Diagnóstico en cardiología. Madrid, Interameri-cana, 1984; 617–627.Google Scholar
  85. 85.
    Gould KL, Goldstein RA, Mullani NA. Economic analysis of clinical positron emission tomography of the heart with rubidium-82. J Nucl Med 1989; 30: 707–717.PubMedGoogle Scholar
  86. 86.
    Franquesa-Graner L. Cálculo de costes en un servicio de medicina nuclear. In: Gómez- Embuena A, Cabranes-Díaz JA, Setoain-Quinquer J, eds. Medicina nuclear, situation actual en Espana y perspectivas de futuro. Madrid, Sociedad españa de medicina nuclear, 1984; 58–63.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1994

Authors and Affiliations

  • P. Galofré-Mora

There are no affiliations available

Personalised recommendations